Cargando…

Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in Elizabethkingia species

OBJECTIVES: Several Elizabethkingia species often exhibit extensive antibiotic resistance, causing infections associated with severe morbidity and high mortality rates worldwide. In this study, we determined fluoroquinolone susceptibility profiles of clinical Elizabethkingia spp. isolates and invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jian, Ming-Jr, Cheng, Yun-Hsiang, Perng, Cherng-Lih, Shang, Hung-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2018
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139017/ https://www.ncbi.nlm.nih.gov/pubmed/30225179 http://dx.doi.org/10.7717/peerj.5608

Ejemplares similares

Multicentre MDR Elizabethkingia anophelis isolates: Novel random amplified polymorphic DNA with capillary electrophoresis systems to rapid molecular typing compared to genomic epidemiology analysis
por: Jian, Ming-Jr, et al.
Publicado: (2019)

Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against Elizabethkingia anophelis Using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
por: Lin, Jiun-Nong, et al.
Publicado: (2021)

Molecular characterization and differential effects of levofloxacin and ciprofloxacin on the potential for developing quinolone resistance among clinical Pseudomonas aeruginosa isolates
por: Kanafani, Zeina A., et al.
Publicado: (2023)

Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin
por: Chen, Chang-Hua, et al.
Publicado: (2017)

Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction
por: Anovadiya, Ashish P., et al.
Publicado: (2011)

In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis
por: Akcali, Sinem, et al.
Publicado: (2005)

Elizabethkingia anophelis: Physiologic and Transcriptomic Responses to Iron Stress
por: Chen, Shicheng, et al.
Publicado: (2020)

Pan-Genomic and Polymorphic Driven Prediction of Antibiotic Resistance in Elizabethkingia
por: Naidenov, Bryan, et al.
Publicado: (2019)

Isolation of Elizabethkingia anophelis From COVID-19 Swab Kits
por: Xu, Liangcai, et al.
Publicado: (2022)

Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli
por: Fu, Yingmei, et al.
Publicado: (2013)

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2021)

Genomic analysis of early transmissibility assessment of the D614G mutant strain of SARS-CoV-2 in travelers returning to Taiwan from the United States of America
por: Jian, Ming-Jr, et al.
Publicado: (2021)

Neonatal Sepsis and Meningitis Caused by Elizabethkingia
por: Kumar, Chanchal, et al.
Publicado: (2021)

P15 Elizabethkingia anophelis became the major Elizabethkingia species in bacteraemia patients in Northern Taiwan
por: Chang, Fu-chieh, et al.
Publicado: (2023)

Biofilm formation and antibiotic sensitivity in Elizabethkingia anophelis
por: Hu, Shaohua, et al.
Publicado: (2022)

Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC
por: KLOSKOWSKI, TOMASZ, et al.
Publicado: (2012)

Novel rapid identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by real-time RT-PCR using BD Max Open System in Taiwan
por: Perng, Cherng-Lih, et al.
Publicado: (2020)

Pseudomonas aeruginosa heteroresistance to levofloxacin caused by upregulated expression of essential genes for DNA replication and repair
por: Li, Wen-Ru, et al.
Publicado: (2022)

Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity
por: Ptaszyńska, Natalia, et al.
Publicado: (2020)

Risk Factors for Mortality in Patients with Elizabethkingia Infection and the Clinical Impact of the Antimicrobial Susceptibility Patterns of Elizabethkingia Species
por: Seong, Hye, et al.
Publicado: (2020)

Chryseobacterium/Elizabethkingia species infections in Saudi Arabia
por: Alyami, Abdulaziz M., et al.
Publicado: (2020)

Isolation and Characterization of a New Phage Infecting Elizabethkingia anophelis and Evaluation of Its Therapeutic Efficacy in vitro and in vivo
por: Peng, Shih-Yi, et al.
Publicado: (2020)

Etymologia: Elizabethkingia
Publicado: (2016)

1425. Population Pharmacokinetic Analysis of Ciprofloxacin and Levofloxacin in Critically Ill Trauma, Surgical, and Burn Patients
por: Ivins-O’Keefe, Kelly, et al.
Publicado: (2018)

Comparative in vitro activity of ciprofloxacin and levofloxacin against isolated uropathogens in Ghana: a pilot study
por: Afriyie, Daniel Kwame, et al.
Publicado: (2018)

Mutational Switch-Backs Can Accelerate Evolution of Francisella to a Combination of Ciprofloxacin and Doxycycline
por: Mehta, Heer H., et al.
Publicado: (2022)

Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori
por: Hanafi, Aimi, et al.
Publicado: (2016)

Single Cell Raman Spectroscopy Deuterium Isotope Probing for Rapid Antimicrobial Susceptibility Test of Elizabethkingia spp.
por: Yuan, Shuying, et al.
Publicado: (2022)

SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance
por: Jian, Ming-Jr, et al.
Publicado: (2022)

Nosocomial infections caused by Elizabethkingia meningoseptica: an emergent pathogen
por: Pereira, Graziella H., et al.
Publicado: (2013)

Post-Keratoplasty Infectious Keratitis Caused by Elizabethkingia meningoseptica
por: Alfaraidi, Albaraa, et al.
Publicado: (2023)

Clinical characteristics analysis of COVID-19 patients from the first significant community outbreak by SARS-CoV-2 variant B.1.1.7 in Taiwan as experienced from a single northern medical center
por: Huang, Ruei-Chang, et al.
Publicado: (2022)

Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2
por: Hangas, Anu, et al.
Publicado: (2018)

Reduced Levofloxacin Susceptibility in Clinical Respiratory Isolates of Haemophilus Influenzae Is Not yet Associated with Mutations in the DNA Gyrase and Topoisomerase II Genes in Korea
por: Kim, In-Suk, et al.
Publicado: (2011)

Contribution of Different Mechanisms to Ciprofloxacin Resistance in Salmonella spp.
por: Chang, Man-Xia, et al.
Publicado: (2021)

Probable Levofloxacin-Induced Thrombocytopenia in a Patient Previously on Ciprofloxacin: A Case Report and Literature Review
por: Landi, A. Justine, et al.
Publicado: (2016)

Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
por: Zusso, Morena, et al.
Publicado: (2019)

Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using In Vitro and In Vivo Models of Q Fever
por: Clay, K. A., et al.
Publicado: (2021)

Ciprofloxacin-Induced Anaphylactic Reaction Followed by Negative Provocation Test in Response to Levofloxacin: A Case Report
por: Kurtov, Marija, et al.
Publicado: (2023)

237. Elizabethkingia species: An Emerging Cause of Healthcare-Associated Bloodstream Infection Among Immunocompromised Hosts
por: Stewart, Adam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6nup42hlcj2e38c46l5e547hf2